Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Unity Biotechnology Inc
(NQ:
UBX
)
1.310
+0.020 (+1.55%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
20,326
Open
1.290
Bid (Size)
1.290 (9)
Ask (Size)
1.300 (5)
Prev. Close
1.290
Today's Range
1.280 - 1.310
52wk Range
1.220 - 3.250
Shares Outstanding
14,601,258
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
UBX Stock Earnings: Unity Biotechnology Beats EPS for Q1 2024
May 14, 2024
UBX stock results show that Unity Biotechnology beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates
May 14, 2024
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
Performance
YTD
-31.77%
-31.77%
1 Month
-19.38%
-19.38%
3 Month
-16.03%
-16.03%
6 Month
-31.41%
-31.41%
1 Year
-55.59%
-55.59%
More News
Read More
UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting
April 25, 2024
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME
April 23, 2024
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
Analyst Ratings for Unity Biotechnology
August 09, 2023
Via
Benzinga
The Latest Analyst Ratings for Unity Biotechnology
June 26, 2023
Via
Benzinga
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
April 17, 2024
Via
Benzinga
UBX Stock Earnings: Unity Biotechnology Beats EPS for Q4 2023
April 15, 2024
Via
InvestorPlace
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
April 15, 2024
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
March 25, 2024
Via
Benzinga
Where Unity Biotechnology Stands With Analysts
May 26, 2023
Via
Benzinga
Recap: Unity Biotechnology Q1 Earnings
May 09, 2023
Via
Benzinga
New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss
February 06, 2024
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
January 19, 2024
Via
Benzinga
UNITY Biotechnology Doses First Patients in Phase 2 ASPIRE Study of UBX1325 in DME
December 12, 2023
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
Unity Biotechnology Upgraded - Analyst Highlights Cash Strength & Execution
November 16, 2023
Via
Benzinga
UNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results and Business Updates
November 13, 2023
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds
November 10, 2023
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
Are Longevity Stocks the Next Trillion-Dollar Industry? 3 Anti-Aging Picks
October 17, 2023
Via
InvestorPlace
UNITY Biotechnology Announces 48-Week Results from Phase 2 ENVISION Study of UBX1325 in Patients with Wet Age-Related Macular Degeneration
September 27, 2023
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
UNITY Biotechnology, Inc. Reports Second Quarter 2023 Financial Results and Business Updates
August 08, 2023
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023
June 26, 2023
Via
Benzinga
UNITY Announces Design of Phase 2b ASPIRE Study Evaluating UBX1325 in Diabetic Macular Edema (DME)
June 21, 2023
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2023
May 31, 2023
Via
Benzinga
UNITY Biotechnology, Inc. Reports First Quarter 2023 Financial Results and Business Updates
May 09, 2023
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.